fda warning letter semaglutide october 2025 to FDA's Office of Prescription Drug Promotion, CDER – Partnership for Safe Medicines Compounded "semaglutide" is not FDA-approved
Description
As of now, Ozempic is not approved for weight loss, while Wegovy is
J Extracell Ves
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment, with common gastrointestinal side effects including nausea and diarrhoea
When youre running on 900 calories a day, you dont have the luxury of wasted nutrition
Some people choose to use both, often at different times of day
Our program enables our patients to lose weight safely and effectively , while staying within Physician approved treatment parameters
